The iconic rise of Viagra has long been a example of pharmaceutical success, but its position within the broader sector now raises questions about future yields . Copycat versions are undercutting patent protection , causing worries that betting on companies closely tied to Viagra's once-dominant standing could be a problematic decision , especiall